| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
135,956 |
128,295 |
$7.04M |
| 64483 |
|
9,802 |
7,178 |
$1.69M |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
31,650 |
30,298 |
$1.17M |
| 64635 |
|
4,522 |
3,741 |
$1.00M |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
11,010 |
10,428 |
$896K |
| 77002 |
|
12,786 |
9,277 |
$711K |
| 64636 |
|
4,582 |
3,518 |
$618K |
| 64493 |
|
5,459 |
3,506 |
$535K |
| 20610 |
|
11,774 |
7,883 |
$520K |
| 64484 |
|
5,917 |
4,296 |
$402K |
| 64494 |
|
4,914 |
3,204 |
$260K |
| 62321 |
|
1,588 |
1,229 |
$243K |
| 20553 |
|
5,436 |
4,387 |
$204K |
| 64633 |
|
963 |
787 |
$185K |
| 64495 |
|
3,255 |
1,955 |
$164K |
| 64634 |
|
1,134 |
834 |
$156K |
| 64490 |
|
1,559 |
889 |
$154K |
| J7321 |
Hyaluronan or derivative, hyalgan, supartz or visco-3, for intra-articular injection, per dose |
1,871 |
961 |
$115K |
| 27096 |
|
733 |
558 |
$101K |
| 64491 |
|
1,556 |
890 |
$79K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
6,203 |
5,787 |
$69K |
| 01992 |
|
777 |
623 |
$66K |
| 64492 |
|
1,288 |
695 |
$64K |
| J1040 |
Injection, methylprednisolone acetate, 80 mg |
4,330 |
3,299 |
$34K |
| 99492 |
|
377 |
370 |
$26K |
| 64450 |
|
1,000 |
269 |
$26K |
| 99152 |
|
893 |
764 |
$24K |
| 80305 |
|
5,802 |
5,017 |
$22K |
| J1030 |
Injection, methylprednisolone acetate, 40 mg |
4,532 |
3,527 |
$19K |
| 64640 |
|
341 |
151 |
$15K |
| 99215 |
Prolong outpt/office vis |
204 |
196 |
$12K |
| J7324 |
Hyaluronan or derivative, orthovisc, for intra-articular injection, per dose |
130 |
48 |
$11K |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
7,867 |
7,310 |
$10K |
| 77003 |
|
322 |
197 |
$6K |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
11,396 |
9,037 |
$6K |
| 01991 |
|
97 |
76 |
$6K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
158 |
127 |
$3K |
| 99484 |
|
146 |
142 |
$3K |
| 20550 |
|
52 |
42 |
$3K |
| J3490 |
Unclassified drugs |
116 |
100 |
$3K |
| S0020 |
Injection, bupivicaine hydrochloride, 30 ml |
2,150 |
1,535 |
$3K |
| Q9967 |
Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml |
14,096 |
10,324 |
$2K |
| 64454 |
|
47 |
25 |
$2K |
| 20526 |
|
14 |
12 |
$1K |
| 80307 |
Drug test(s), presumptive, any number of drug classes; immunoassay |
32 |
32 |
$765.17 |
| 76942 |
|
16 |
14 |
$586.56 |
| 94761 |
|
690 |
417 |
$84.48 |
| J7030 |
Infusion, normal saline solution , 1000 cc |
75 |
46 |
$70.50 |
| A9577 |
Injection, gadobenate dimeglumine (multihance), per ml |
14 |
14 |
$30.74 |
| J2001 |
Injection, lidocaine hcl for intravenous infusion, 10 mg |
2,175 |
1,647 |
$20.25 |
| 96127 |
|
61 |
53 |
$9.19 |
| 93770 |
|
489 |
337 |
$7.15 |